These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 29914893)

  • 21. Evaluation of the clinical significance of lymphocyte subsets and myeloid suppressor cells in patients with renal carcinoma.
    Li Y; Wu Z; Ni C; Li Y; Wang P
    Discov Oncol; 2024 Sep; 15(1):512. PubMed ID: 39347882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In Vitro Generation of Human Neutrophilic Myeloid-Derived Suppressor Cells.
    Singh A; Rieber N
    Methods Mol Biol; 2021; 2236():77-83. PubMed ID: 33237542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Granulocytic myeloid-derived suppressor cells are cryosensitive and their frequency does not correlate with serum concentrations of colony-stimulating factors in head and neck cancer.
    Trellakis S; Bruderek K; Hütte J; Elian M; Hoffmann TK; Lang S; Brandau S
    Innate Immun; 2013 Jun; 19(3):328-36. PubMed ID: 23160385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myeloid-Derived Suppressor Cells as an Immune Parameter in Patients with Concurrent Sunitinib and Stereotactic Body Radiotherapy.
    Chen HM; Ma G; Gildener-Leapman N; Eisenstein S; Coakley BA; Ozao J; Mandeli J; Divino C; Schwartz M; Sung M; Ferris R; Kao J; Wang LH; Pan PY; Ko EC; Chen SH
    Clin Cancer Res; 2015 Sep; 21(18):4073-4085. PubMed ID: 25922428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD205
    Fu C; Fu Z; Jiang C; Xia C; Zhang Y; Gu X; Zheng K; Zhou D; Tang S; Lyu S; Ma S
    Cancer Sci; 2021 Mar; 112(3):1011-1025. PubMed ID: 33368883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-infiltrating and circulating granulocytic myeloid-derived suppressor cells correlate with disease activity and adverse clinical outcomes in mycosis fungoides.
    Argyropoulos KV; Pulitzer M; Perez S; Korkolopoulou P; Angelopoulou M; Baxevanis C; Palomba ML; Siakantaris M
    Clin Transl Oncol; 2020 Jul; 22(7):1059-1066. PubMed ID: 31696413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human Head and Neck Squamous Cell Carcinoma-Associated Semaphorin 4D Induces Expansion of Myeloid-Derived Suppressor Cells.
    Younis RH; Han KL; Webb TJ
    J Immunol; 2016 Feb; 196(3):1419-29. PubMed ID: 26740106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD4+ T effector memory cell dysfunction is associated with the accumulation of granulocytic myeloid-derived suppressor cells in glioblastoma patients.
    Dubinski D; Wölfer J; Hasselblatt M; Schneider-Hohendorf T; Bogdahn U; Stummer W; Wiendl H; Grauer OM
    Neuro Oncol; 2016 Jun; 18(6):807-18. PubMed ID: 26578623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endoplasmic reticulum stress induced LOX-1
    Nan J; Xing YF; Hu B; Tang JX; Dong HM; He YM; Ruan DY; Ye QJ; Cai JR; Ma XK; Chen J; Cai XR; Lin ZX; Wu XY; Li X
    Immunology; 2018 May; 154(1):144-155. PubMed ID: 29211299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood Myeloid-Derived Suppressor Cells Correlate with Neutrophil-to-Lymphocyte Ratio and Overall Survival in Metastatic Urothelial Carcinoma.
    Sheng IY; Diaz-Montero CM; Rayman P; Wei W; Finke JH; Kim JS; Pavicic PG; Lamenza M; Company D; Stephenson A; Campbell S; Haber G; Lee B; Mian O; Gilligan TD; Rini BI; Garcia JA; Grivas P; Ornstein MC
    Target Oncol; 2020 Apr; 15(2):211-220. PubMed ID: 32207064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Relevance and Immunosuppressive Pattern of Circulating and Infiltrating Subsets of Myeloid-Derived Suppressor Cells (MDSCs) in Epithelial Ovarian Cancer.
    Okła K; Czerwonka A; Wawruszak A; Bobiński M; Bilska M; Tarkowski R; Bednarek W; Wertel I; Kotarski J
    Front Immunol; 2019; 10():691. PubMed ID: 31001284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Granulocyte Progenitor Stage Is a Key Target of IRF8-Mediated Regulation of Myeloid-Derived Suppressor Cell Production.
    Netherby CS; Messmer MN; Burkard-Mandel L; Colligan S; Miller A; Cortes Gomez E; Wang J; Nemeth MJ; Abrams SI
    J Immunol; 2017 May; 198(10):4129-4139. PubMed ID: 28356386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expansion of Functional Myeloid-Derived Suppressor Cells in Controlled Human Malaria Infection.
    Lamsfus Calle C; Fendel R; Singh A; Richie TL; Hoffman SL; Kremsner PG; Mordmüller B
    Front Immunol; 2021; 12():625712. PubMed ID: 33815377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myeloid-derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties.
    Brandau S; Trellakis S; Bruderek K; Schmaltz D; Steller G; Elian M; Suttmann H; Schenck M; Welling J; Zabel P; Lang S
    J Leukoc Biol; 2011 Feb; 89(2):311-7. PubMed ID: 21106641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cetuximab ameliorates suppressive phenotypes of myeloid antigen presenting cells in head and neck cancer patients.
    Li J; Srivastava RM; Ettyreddy A; Ferris RL
    J Immunother Cancer; 2015; 3():54. PubMed ID: 26579227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential expansion of circulating human MDSC subsets in patients with cancer, infection and inflammation.
    Cassetta L; Bruderek K; Skrzeczynska-Moncznik J; Osiecka O; Hu X; Rundgren IM; Lin A; Santegoets K; Horzum U; Godinho-Santos A; Zelinskyy G; Garcia-Tellez T; Bjelica S; Taciak B; Kittang AO; Höing B; Lang S; Dixon M; Müller V; Utikal JS; Karakoç D; Yilmaz KB; Górka E; Bodnar L; Anastasiou OE; Bourgeois C; Badura R; Kapinska-Mrowiecka M; Gotic M; Ter Laan M; Kers-Rebel E; Król M; Santibañez JF; Müller-Trutwin M; Dittmer U; de Sousa AE; Esendağlı G; Adema G; Loré K; Ersvær E; Umansky V; Pollard JW; Cichy J; Brandau S
    J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32907925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new procedure to analyze polymorphonuclear myeloid derived suppressor cells in cryopreserved samples cells by flow cytometry.
    Sacchi A; Tumino N; Grassi G; Casetti R; Cimini E; Bordoni V; Ammassari A; Antinori A; Agrati C
    PLoS One; 2018; 13(8):e0202920. PubMed ID: 30161175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients.
    Marini O; Spina C; Mimiola E; Cassaro A; Malerba G; Todeschini G; Perbellini O; Scupoli M; Carli G; Facchinelli D; Cassatella M; Scapini P; Tecchio C
    Oncotarget; 2016 May; 7(19):27676-88. PubMed ID: 27050283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myeloid-Derived Suppressor Cells in Kidney Transplant Recipients and the Effect of Maintenance Immunotherapy.
    Iglesias-Escudero M; Sansegundo-Arribas D; Riquelme P; Merino-Fernández D; Guiral-Foz S; Pérez C; Valero R; Ruiz JC; Rodrigo E; Lamadrid-Perojo P; Hutchinson JA; Ochando J; López-Hoyos M
    Front Immunol; 2020; 11():643. PubMed ID: 32425928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myeloid-Derived Suppressor Cell Subset Accumulation in Renal Cell Carcinoma Parenchyma Is Associated with Intratumoral Expression of IL1β, IL8, CXCL5, and Mip-1α.
    Najjar YG; Rayman P; Jia X; Pavicic PG; Rini BI; Tannenbaum C; Ko J; Haywood S; Cohen P; Hamilton T; Diaz-Montero CM; Finke J
    Clin Cancer Res; 2017 May; 23(9):2346-2355. PubMed ID: 27799249
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.